University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Biochemistry -- Faculty Publications

Biochemistry, Department of

2016

Systems Perturbation Analysis of a Large-Scale
Signal Transduction Model Reveals Potentially
Influential Candidates for Cancer Therapeutics
Bhanwar Lal Puniya
University of Nebraska-Lincoln, puniya.bl@gmail.com

Laura Allen
University of Nebraska at Omaha

Colleen Hochfelde
Albert Einstein College of Medicine, New York, hochfeld@mail.einstein.yu.edu

Mahbubul Majumder
University of Nebraska at Omaha, mmajumder@unomaha.edu

Tomáš Helikar
University of Nebraska–Lincoln, thelikar2@unl.edu

Follow this and additional works at: https://digitalcommons.unl.edu/biochemfacpub
Part of the Biochemistry Commons, Biotechnology Commons, and the Other Biochemistry,
Biophysics, and Structural Biology Commons
Puniya, Bhanwar Lal; Allen, Laura; Hochfelde, Colleen; Majumder, Mahbubul; and Helikar, Tomáš, "Systems Perturbation Analysis of
a Large-Scale Signal Transduction Model Reveals Potentially Influential Candidates for Cancer Therapeutics" (2016). Biochemistry -Faculty Publications. 163.
https://digitalcommons.unl.edu/biochemfacpub/163

This Article is brought to you for free and open access by the Biochemistry, Department of at DigitalCommons@University of Nebraska - Lincoln. It
has been accepted for inclusion in Biochemistry -- Faculty Publications by an authorized administrator of DigitalCommons@University of Nebraska Lincoln.

•

frontiers
in Bioengineering and Biotechnology

ORIGINAL RESEARCH
published: 11 February 2016
doi: 10.3389/fbioe.2016.00010

Open Access licensed.

®

CrossMark

Systems Perturbation Analysis of a
Large-Scale Signal Transduction
Model Reveals Potentially Influential
Candidates for Cancer Therapeutics
Bhanwar Lal Puniya 1 , Laura Allew, Colleen Hochfelder, Mahbubul Majumder2 and
Tomas Helikar1*
1 Department of Biochemistry, University of Nebraska-Uncoln, Uncoln, NE, USA, 2 Department of Mathematics, University of
Nebraska at Omaha, Omaha, NE, USA, 3 Albert Einstein College of Medicine, New York, NY; USA

OPEN ACCESS
Edited by:
David A. Rosenblueth,
Universidad Nacional Aut6noma de
Mexico, Mexico
Reviewed by:

Reka Albert,
Pennsylvania State University, USA
Ovidiu Radulescu,
Universite de Montpellier 2, France
'Correspondence:

Tomas Helikar
thelikar2@unl.edu
Specialty section:

This article was submitted to
Bioinformatics and
Computational Biology,
a section of the joumal
Frontiers in Bioengineering and
Biotechnology
Received: 01 November 2015
Accepted: 25 January 2016
Published: 11 February 2016
Citation:

Puniya BL, Allen L, Hochfelder C,
Majumder M and Helikar T (2016)
Systems Perturbation Analysis of a
Large-Scale Signal Transduction
Model Reveals Potentially Influential
Candidates for Cancer Therapeutics.
Front. Bioeng. Biotechnol. 4: to.
doi: 10.3389lfbioe.2016.00010

Dysregulation in signal transduction pathways can lead to a variety of complex disorders,
including cancer. Computational approaches such as network analysis are important tools
to understand system dynamics as well as to identify critical components that could be
further explored as therapeutic targets. Here, we performed perturbation analysis of a
large-scale signal transduction model in extracellular environments that stimulate cell death,
growth, motility, and quiescence. Each of the model's components was perturbed under
both loss-of-function and gain-of-function mutations. Using 1,300 simulations under both
types of perturbations across various extracellular conditions, we identified the most and
least influential components based on the magnitude of their influence on the rest of the
system. Based on the premise that the most influential components might serve as better
drug targets, we characterized them for biological functions, housekeeping genes, essential
genes, and druggable proteins. The most influential components under all environmental
conditions were enriched with several biological processes. The inositol pathway was found
as most influential under inactivating perturbations, whereas the kinase and small lung
cancer pathways were identified as the most influential under activating perturbations. The
most influential components were enriched with essential genes and druggable proteins.
Moreover, known cancer drug targets were also classified in influential components based
on the affected components in the network. Additionally, the systemic perturbation analysis
of the model revealed a network motif of most influential components which affect each
other. Furthermore, our analysis predicted novel combinations of cancer drug targets with
various effects on other most influential components. We found that the combinatorial perturbation consisting of PI3K inactivation and overactivation of IP3R1 can lead to increased
activity levels of apoptosis-related components and tumor-suppressor genes, suggesting
that this combinatorial perturbation may lead to a better target for decreasing cell proliferation and inducing apoptosis. Finally, our approach shows a potential to identify and prioritize
therapeutic targets through systemic perturbation analysis of large-scale computational
models of signal transduction. Although some components of the presented computational
results have been validated against independent gene expression data sets, more laboratory experiments are warranted to more comprehensively validate the presented results.
Keywords: computational modeling, in silico perturbation analysis, signal transduction, cancer, therapeutic
targets
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INTRODUCTION

wide spectrum of biological systems ranging in size as well as
contextual application (Naldi et al., 2010; Helikar et al., 2012;
Madrahimov et al., 2013; Rocha et al., 2013; Conroy et al., 2014).
Thus, applying perturbation analysis to large-scale logical models
may provide new insights into the system, which could be used to
identify novel therapeutic targets.
Herein, we present results from a system-wide perturbation
analysis of a large-scale Boolean model of a signal transduction
network widely present in many types of cells. Specifically, the
model previously described in Helikar et al. (2008) represents
signaling events within the integrated epidermal growth factor (EGF), G protein-coupled receptor, and integrin signaling
network. The model consists of 137 components (mostly proteins) and 557 biochemical interactions. The simulation-based,
system-wide perturbation analyses enabled us to identify the
most and least influential components (ones with the most and
least impact on the rest of the network). To explore the role
and effects of these perturbations in the context of the complex
extracellular environment, the simulations and analyses were
conducted under four biologically relevant environmental
conditions known to stimulate cell growth, cell death, motility, and quiescence (in addition to a set of randomly generated environmental stimuli). In order to investigate potential
therapeutic targets, we performed functional annotation and
analysis of the most influential signal transduction components under both inactivating (e.g., knockout) and activating
(e.g., overexpression) perturbations. The most influential
components were found to be enriched with many biological
processes and druggable targets. Also, the most influential
components under activating perturbations were enriched
with more essential genes than the least influential components.
We used the most influential components and their upstream
regulators to identify novel interactions. We also identified a
network of the most influential components consisting of drug
targets considered in multiple cancer types. The highest ranked
among the most influential components were already explored
as drug targets against cancer, including EGFR, PI3K, Raf, Ras,
and Erk. Because some of these targets have been reported
to be associated with drug resistance (Holohan et al., 2013;
Rodon et al., 2013; Wagle et al., 2014), we analyzed additional
components of the signal transduction network that could
potentially complement drug-resistant targets. As a result of
the systemic analysis, we identified one novel combinatorial
target, PI3K–IP3R1, with consistent occurrence in all simulated
environmental conditions. This combination could be used to
suppress cell proliferation while increasing the rate of apoptosis.
We simulated the effect of combinatorial perturbation and the
results were correlated with the literature, further supporting
our predictions.

Recent advances in systems biology and computational biology
have introduced methods for the visualization, comprehension,
and interpretation of big data in biomedical research. These fields
provide an array of methodologies including computer simulations that can be used to generate new hypotheses and identify
which hypotheses might be more productive to undertake experimentally, and eliminate hypotheses with little chance of success
(Kitano, 2002a,b; Ghosh et al., 2011). These methods can be effective in navigating complex network problems associated with diseases. Many diseases and pathologies can be characterized by the
dysregulation or dysfunction of multiple molecular components
that are connected within these highly intertwined biological and
biochemical networks (Loscalzo and Barabasi, 2011). Biological
networks, including biochemical signal transduction networks,
consist of a large number of highly interconnected pathways that
give rise to complex, non-linear dynamics governing various cellular functions (Helikar et al., 2008; Helikar and Rogers, 2009).
Disruptions of these networks, such as mutations or disease states
can have drastic effects upon the whole system. These effects are
difficult to predict from static network diagrams.
However, understanding the hierarchy of these changes
remains a paramount problem. Often the specific causal interactions of the disease state are hidden within the massive cell-wide
alterations, making attempts to reverse a disease state more challenging. In addition, the specific causal interactions are difficult
to predict making the development of a potential therapeutic
target results in unforeseen side effects (Singh and Singh, 2012).
The unwanted effects of these drugs are often drastic as seen with
many cancer medications (Kayl and Meyers, 2006; Lotfi-Jam
et al., 2008; Singh and Singh, 2012). These challenges are further
exacerbated by drug resistance that can render therapies ineffective. Therefore, it is necessary to gain a systems level understanding of the components associated with the disease states.
In recent years, targeted therapy has been used for multiple
diseases, e.g., cancer (Vanneman and Dranoff, 2012), and often
involve the activation or inactivation of a specific component in
a biological network by a small molecule or drug, for instance.
Perturbation analyses allow one to interrogate the structure
and dynamic footprint of the underlying biological system.
Perturbation biology has been proposed as an approach to
reduce the collateral damage caused by non-specific drugs.
Computational network perturbations and new methods to
evaluate the robustness of a given network can help identify more
effective network components to target in order to obtain desired
outcomes with minimal disruption to the rest of the network
(Molinelli et al., 2013).
In order to fully leverage the potential of computational
network perturbation analyses large dynamical models are
necessary. A wide spectrum of modeling approaches exists ranging from detailed (but less scalable) differential equation-based
systems to large (but not dynamic) static networks. In the middle are approaches such as logical modeling that are relatively
scalable while capable of capturing the dynamic nature of
biological systems (Le Novère, 2015). Logical networks, namely
Boolean networks, have been used to describe and simulate a
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MATERIALS AND METHODS
Computational Model

The computational model analyzed in this work is a Boolean
model of signal transduction in a generic cell type. In Boolean
models, each component can assume an active (1) or inactive
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(0) state at any time t. The activity state of the model’s internal
components is determined by the regulatory mechanisms
of other directly interacting components. These regulatory
mechanisms are described with Boolean functions (in the
form of truth tables or Boolean expressions). To represent
the milieu of stimuli in the extracellular environment, the
model contains external components that represent various
ligands. The activity level of these components is specified
as a probability to simulate different levels of concentrations.
This methodology was previously detailed and exemplified in
Helikar et al. (2008, 2012), Helikar and Rogers (2009), and
Todd and Helikar (2012).
The signal transduction model, previously detailed in Helikar
et al. (2008), was constructed manually from around 500
published papers. The model consists of several main signaling
pathways, including the receptor tyrosine kinase (EGF receptor),
G protein-coupled receptors (G-alpha i, G-alpha q, G-alpha s,
and G-alpha 12/13), and the integrin signaling pathways. Each
of the 130 components in the model corresponds to a signaling
molecule (mainly protein). The model also contains nine external
components that represent the extracellular environment (mostly
composed of receptor ligands). These external components
include the EGF, extracellular matrix (ECM), calcium pump,
interleukin 1, and tumor necrosis factor (TNF), ligands for four
types of G protein-coupled receptors (αi, αq, αs, and 12/13), and a
general stress signal. The final model consists of 137 components
(130 internal and 7 external) connected with 557 interactions.
The model is fully annotated and freely available via the Cell
Collective software (Helikar et al., 2012, 2013) at www.thecellcollective.org (under Published Models). Cell Collective, an
interactive modeling environment, can be used to download the
model (and other logical models published by the community)
in several file formats (SBML qual, text file of logical functions,
truth tables, etc.), as well as simulate directly on the platform. For
convenience, the model SBML file is provided as File S1 (Data
Sheet 1) in Supplementary Material.

death, quiescence, motility (and randomly generated behaviors),
as established and detailed in Helikar et al. (2008). The environmental conditions that stimulate each of these cellular responses
were obtained based on Helikar et al. (2008) where the model’s
responses were characterized based on 10,000 combinations of
randomly generated environmental signals. For example, cell
growth behavior is characterized by higher AL of Erk (marker
for proliferation) and Akt (marker for anti-apoptosis). Cell
motility behavior was characterized by higher AL of Cdc42 and
Rac. Quiescence response is considered when the activity level
of Akt is medium to low, and proliferation (Erk) and motility
(Cdc42 and Rac) are low or inactive (Helikar et al., 2008). Each
environmental condition is defined by different combinations of
AL of external components (ligands). The activity level ranges
of the environmental conditions were further determined by an
optimization method whereby 2,000 simulations were run with
all external stimuli ranging from 0 to 100 (except for IL1_TNF
and Stress that were limited to low AL). Subsequently, environmental activity level combinations that stimulated cell growth,
cell death, motility, and quiescence most effectively were selected
as the corresponding environmental conditions (Table 1). This
is directly analogous to optimization experiments in laboratory
studies (e.g., determining the optimal medium and plating conditions of a cell before performing a growth factor titration).
A wild type (WT) experiment (used as a reference) was
conducted under each environmental condition without any perturbations. Subsequently, systematic perturbation experiments
were conducted under each condition, whereby each component
of the model was constitutively activated (activity stuck at 1;
gain-of-function/overexpression) or inactivated (activity stuck
at 0; loss-of-function/knockout). Each experiment consisted
of randomly selecting 100 combinations of AL of the external
stimuli from each condition activity range. (The only exception
was the random environmental condition, which was simulated
2,000 times.) Each of the 100 combinations were simulated 30
times (i.e., 30 replicates) to ensure consistency of the dynamics
in response to a specific combination of stimuli. These replicates
were subjected to a Fligner Killeen test of homogeneity of
variances, which confirmed that the measured AL of the network
components, were homologous for identical combinations of AL
of the environmental stimuli.

Model Simulations

The Cell Collective platform was used to perform all computational simulations of the model. Although the model is built by
using discrete mathematics the output activity levels (AL) can
be continuous (ranging from 0 to 100) as previously described
in Helikar et al. (2008) and Helikar and Rogers (2009). Each
simulation is synchronous and consists of 800 steps, where the
activity level of the measured output component is calculated
as the fraction of ones (active states) over the last 300 iterations
that describe the network’s steady behavior (Helikar et al., 2008;
Helikar and Rogers, 2009).
Let xj(ti) denotes a node’s activity on the ith iteration and jth
simulation where i = 1, 2, …, T and j = 1, 2, …, N, total is the
simulation out of N total simulations. We obtain AL as below.
AL =

Model Analysis

The Kolmogorov–Smirnov (KS) test (Wang et al., 2003) was used
to compare the WT dynamics (under each environmental condition) with the dynamics of each perturbation experiment. If the
KS test resulted in a p-value <0.05, then it has a difference value
(DV) equal to the test statistic; otherwise, the DV for a component is 0. Because we are looking at how a node’s perturbation
affects the rest of the network, its DV when it is the perturbed
node is set to 0.

1 N T
∑ ∑ x j (ti )
300N j =1 i =T − 300

Most and Least Influential Components

The most influential components are defined as components that
induce the largest changes in the network under a given perturbation. The ranking of the perturbations is derived by calculating

The model was simulated and analyzed under four biologically
relevant environmental conditions that stimulate cell growth, cell
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Table 1 | Activity level ranges of environmental stimuli for cell death, growth, motility, quiescence, and random environments.
External

Death

Growth

Extracellular matrix (ECM)
Epidermal growth factor (EGF)
Calcium pump (ExtPump)
GPCR q ligand (alpha_qL)
GPCR i ligand (alpha_iL)
GPCR s ligand (alpha_sL)
GPCR 12/13 ligand (alpha_1213L)
IL1_TNF
Stress

10–72
3–15
35–87
13–58
1–4
30–87
14–65
4–13
2–5

26–82
72–97
24–83
18–78
15–77
24–80
18–78
8–15
2–5

81–99
29–83
41–92
17–74
30–82
20–77
12–77
4–13
2–5

Quiescence
7–30
43–56
17–82
4–84
31–83
19–46
18–67
2
2–3

Random
0–100
0–100
0–100
0–100
0–100
0–100
0–100
2
2

Network Motif Analysis

an influence score (IS) for the ith node, which is found by summing the DV for all M nodes in the network. The top 10% are
considered most influential, and the bottom components with IS
value 0 were considered the least influential. The cutoffs were set
to 10% because only a few components had a high influence on
the network.

Network motif analysis in the directed signal transduction
network was performed using FANMOD tool (Wernicke and
Rasche, 2006). The default parameters were used that include
100,000 samples to determine the sub-graphs. The significance
of network was computed by comparison with 1,000 random
networks. Network motifs that have occurrence more than five
times and p-value <0.05 were considered as significant. Network
motif analysis was previously integrated with logical modeling
of signal transduction of epithelial–mesenchymal transition
(Steinway et al., 2014).

M

ISi = ∑ DVij
j =1

i = 1, ,130

Most Affected Components to a Specific
Perturbation

Gene Expression Analysis

To investigate the functional activity of the components of signal
transduction model, we queried publicly available gene expression
data in four different databases (Consortium, 2011); Bgee (gives
activity level of genes across different species as well as different
developmental stages) (Bastian et al., 2008), CleanEx database
(Providing heterogenous data from different) (Praz et al., 2004),
Expression Atlas database (gene expression data under different
biological conditions) (Petryszak et al., 2014), and GeneVisible
database (Gene expression in different tissues) (Zimmermann
et al., 2004). Out of 109 signal transduction components i.e.,
proteins, 107 (~98%) showed expression across different species,
developmental stages, organs, and tissues – suggesting the biological activity of signal transduction network. Gene expression
status of signal transduction components is shown in the Table S1
in Supplementary Material.
The gene expression dataset GSE53309 was obtained from
the GEO database (Barrett et al., 2005; Rosich et al., 2014).
We selected samples that were treated with pan-PI3K inhibitor and of normal control. The log 2 RMA signal intensities of
samples were transformed into Z-scores (Cheadle et al., 2003).
To compare the Z-scores of treated samples with normal control, we used Z-ratio approach. Genes with Z-ratio ≥1.50 were
considered upregulated and with ≤−1.50 were considered as
downregulated. The Z-ratio cut-off (1.5) is previously found as
robust (Cheadle et al., 2003). The genes of signal transduction
components whose AL were affected as a result of PI3K inactivation were examined for Z-ratios in both the biological replicates.
We used DAVID to perform biological process enrichment
analysis of upregulated and downregulated genes. The high
stringency and FDR < 5% were used to select significantly
enriched biological processes.

For each perturbation induced, the components that are most
sensitive to that perturbation are ranked in decreasing order to
be able to characterize downstream effects of the perturbation
on the network.

Annotation and Biological Relevance of
Signal Transduction Components

All model components were first annotated using the appropriate NCBI gene IDs (Pruitt et al., 2007) for associated genes and
UniProt IDs (Consortium, 2011) for protein products of the
genes. All components were then further characterized using
online resources such as DrugBank (Wishart et al., 2006).
The biological process enrichment analysis of the most influential components was done using DAVID (Huang et al., 2008),
with high stringency. Gene Ontology (Ashburner et al., 2000),
SP_PIR keywords, and KEGG pathways (Kanehisa, 2002) were
obtained using FDR < 5%.
Essentiality data were obtained from the Online GEne
Essentiality (OGEE) database and mapped on the most and least
influential components (Chen et al., 2012). DrugBank data were
used to obtain druggability information for each component
in the network. Data on cancer-associated genes were obtained
from The Cancer Genome Atlas (TCGA) (Weinstein et al., 2013)
and mapped on the most influential components to identify
cancer-associated most influential components. The enrichment
of essential genes and druggable proteins was computed based
on the number of genes mapped on most or least influential
components out of the total number of most and least influential
components.
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RESULTS

Also, the most influential components correspond to network
components that, when perturbed, affect the largest part of the
network in terms of the number of affected components and the
magnitude of the effect. The most influential components were
found for both inactivating (Figure 2A) and activating (Figure 2B)
perturbations under the different environmental conditions. It is
interesting to note that many of the most influential components
overlap across all environmental conditions. However, the most
influential components do not overlap between two types of perturbations (inactivating or activating). We investigated whether the
most influential components that spanned different environmental
conditions could function as housekeeping genes. Also, the most
influential components that are specifically found under one environmental condition should have association with that condition.

System-Wide Perturbation Analysis
Reveals Core Components of the Signal
Transduction Network

A critical objective of biomedical research is the identification and
prioritization of novel therapeutic targets. In this context, we performed systematic perturbation analysis in a generic signal transduction model. The workflow used in this work is illustrated in Figure 1.
The activating/inactivating perturbation experiments for each
component in the model were carried out across four environmental
conditions (as described in the Section “Materials and Methods”).
Additional randomly generated extracellular conditions were used to
check the robustness of the model and results. Perturbation analysis
enabled us to identify and rank components of the signaling network that are most and least influential (Table S2 in Supplementary
Material). The heatmaps for all the environmental conditions
[Figures S1–S10 (Image 1) in Supplementary Material] indicate that a
few components had high influence on rest of the system. Therefore,
we considered the top 10% of the components from each condition as
the most influential. By contrast, the components that had no influence on the system were considered as the least influential (KS = 0).

Housekeeping Genes Are Enriched in the Most
Influential Components Common in Different
Environments

Housekeeping genes are defined as genes expressed at constant level
in many cells and under many conditions (Eisenberg and Levanon,
2013). Therefore, components that were identified as most influential
under all of the simulated environmental conditions can be hypothesized to have housekeeping function. To investigate this, we compared
these most influential components with known housekeeping genes
as provided in Eisenberg and Levanon (2013). Under inactivating
perturbations, out of the seven components common among the
different environmental conditions, PI4K, PI5K, ARF, and PI3K were
associated with housekeeping genes (Eisenberg and Levanon, 2013).
Under activating perturbations, Trafs, Erk, Mek, and SHP2 (out of
nine common components), were associated with housekeeping
genes. Housekeeping genes associated with the common components
are displayed in Table 2. This observation suggests that the most influential components that are common among different environmental
conditions are likely to function as housekeeping genes.

Unique Components Associated with Each
Environmental Condition Are Found to Be Condition
Specific

Under both types of perturbations, certain environmental conditions had several uniquely associated components (Figure 2;
Table 3). Under inactivating perturbations, components uniquely

Figure 1 | Overview of the method used to assess influential
components in the model.

Figure 2 | Comparison of the most influential components across simulated environmental conditions. (A) Inactivating perturbations, (B) activating
perturbations.
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Table 2 | Housekeeping genes in the most influential components overlapped among different environmental conditions.
Perturbation

Components

Genes

Housekeeping genesa

Inactivating

PI4K
PI5K
ARF
PP2A
PI3K

PI4KA, PI4KB, PIK4CB
PIP5K1A, PIP5K1B, PIP5K1C
ARFGAP1, ARFGAP2, ARFGAP3
PPP2CA
PIK3CA, PIK3CB, PIK3CD, PIK3CG

PI4KA, PI4KB
PIP5K1A
ARFGAP2, ARFGAP3
PPP2CA
PIK3C3, PIK3CB

Activating

EGFR
IL1_TNFR
TRAFS
ERK
MEK
PKC
GAB1
SHP2

EGFR
IL1B, TNFRSF1A
TRAF1, TRAF2, TRAF3, TRAF4, TRAF5, TRAF6, TRAF7
MAPK1 to MAPK15
MAP2K1 to MAP2K7
PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ
GAB1
PTPN11

No
No
TRAF6, TRAF7
MAPK1, MAPK6, MAPK8, MAPK9
MAP2K1, MAP2K2, MAP2K5
No
No
PTPN11

a

List of housekeeping genes were obtained from Eisenberg and Levanon (2013).

Table 3 | Condition-specific components and literature support.
Perturbations

Environmental condition

Associated components

Literature

Inactivating

Death

CaM, RGS, Palpha_iR

CaM- and CaM-dependent signaling systems control vertebrate cell
proliferation, programed cell death, and autophagy (Berchtold and
Villalobo, 2014). RGS is involved in cell death (Fisher, 2009)

Activating

Death

Gbg_i (GNB), Alpha_iR

Growth

PP2A

Motility

KRAS, Sos

Gbg_i has been hypothesized to be involved in mTOR-mediated antiapoptotic pathways. Furthermore, it has been functionally annotated with
apoptosis, cell death (Wazir et al., 2013)
Highly regulated family of Ser/Thr phosphatase implicated in cell growth
and signaling (Janssens and Goris, 2001)
Knockdown of KRAS in pancreatic cancer cell lines leads to decreased
motility and proliferation. The Grb2–Sos1 complex may promote cell
motility, and tumerogenesis (Qu et al., 2014)

the literature evidence obtained for housekeeping, or condition
associated genes, further supports our simulation results.

associated with the cell death stimulating condition are calmodulin (CaM), RGS, and Palpha_iR. Out of these, CaM and RGS have
been previously associated with cell death and apoptosis (Fisher,
2009; Berchtold and Villalobo, 2014). In fact, CaM plays a central
role in the regulation of several cellular functions, including
programed cell death (Berchtold and Villalobo, 2014). It is also
known that RGS protein can regulate cell death, cell cycle, and cell
division (Fisher, 2009). Under activating perturbations, the most
influential components associated with the cell death-inducing
condition include Gbg_i and Alpha_iR. On the other hand, PP2A
was found to be most influential under the growth stimulating
condition, Ras and Sos under motility stimulating condition,
and PAK under quiescence stimulating condition. These results
are also further supported by published studies that reported
Gbg_i (GNB) to be involved in mTOR-mediated anti-apoptotic
pathways; Gbg_i was also functionally annotated with apoptosis
and cell death (Wazir et al., 2013). PP2A was reported as a highly
regulated Ser/Thr phosphatase involved in cell growth and signaling (Janssens and Goris, 2001). In pancreatic cancer cell lines, the
knockdown of KRAS has been found to lead to the decrease in cell
motility and proliferation (Rachagani et al., 2011; Birkeland et al.,
2012). Furthermore, the Grb2–Sos1 complex has been found to
most likely promote cell motility, and tumerogenesis (Qu et al.,
2014). These observations suggest that the proteins, which were
uniquely associated with simulated environmental conditions,
are most likely to have the association with that condition. Finally,
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Key Biological Processes Are Enriched in
the Most Influential Components

Next, we assessed the enrichment of biological processes or
pathways in the most influential components. The most influential components across all four conditions under both types of
perturbation showed significant enrichment with key biological
processes. The counts and fold differences of enriched biological
terms in all the conditions are shown in Figures 3 and 4. In the
case of inactivating perturbations, inositol phosphate metabolism
was enriched under all environmental conditions (Figure 3). In
the case of activating perturbations, the significantly enriched
biological processes include phosphate metabolic processes,
kinase activity, apoptosis, and, interestingly, the non-small lung
cancer pathway (Figure 4). These results illustrate that the group
of proteins with similar biological functions appear as the influential components under each type of perturbation.

The Most Influential Components under
Activating Perturbations Are Enriched with
Essential Genes

Mutations in an essential gene can be lethal. Based on the hypothesis that the influential components might serve as essential for
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Figure 3 | Enriched biological processes in the most influential components under environmental conditions, and inactivating perturbations.
(A) Death (B) growth (C) motility and (D) quiescence.

the survival of the cell, we performed essentiality analysis. We
mapped essential genes on the most influential components
and on the least influential components. The essential genes
mapped on the most influential components were compared
with essential genes mapped on the least influential components.
Under activating perturbations, more essential genes were found
within the most influential components than the least influential
components (Figure 5A). Under the cell death stimulating condition, a total of 69% of the most influential components were
essential; this is in contrast to the least influential components
that contained 31% essential genes. Under other environmental
conditions stimulating growth, motility, and quiescence, the difference of essential genes between the most influential and the
least influential components are 23, 15, and 32%, respectively.
On the other hand, under inactivating perturbations, we found
either an equal or larger number of essential genes in the least
influential components (Figure 5B). The most significant differences were observed under the cell death stimulating conditions:
the least influential components have 66% of essential genes in
contrast to the 46% essential genes in the most influential. Also,
under the growth stimulating conditions, 68 and 53% of essential
genes were contained within the least and the most influential
components, respectively. Under the motility and quiescence
stimulating conditions, there were 3 and 9% more essential genes

Frontiers in Bioengineering and Biotechnology | www.frontiersin.org

within the least influential components than the most influential
components, respectively. We found that under inactivating
perturbations, the number of essential genes among the least
influential components was slightly larger than the activating perturbation (Figures 5C,D). On the other hand, under activating
perturbations, the more essential genes mapped within the most
influential components than the least influential components.
Thus, the most influential components are essential under
activating perturbations, suggesting an environmental conditionspecific essentiality.

The Most Influential Components Are
Enriched with Druggable Proteins

To further investigate the importance of the most influential
components, we evaluated the distribution of known druggable
targets. We obtained druggability data from the DrugBank
database (Wishart et al., 2006) and mapped them on the most
and least influential components. A total of 51 components in the
whole network were enriched with druggable proteins. We compared druggable proteins within the most influential components
with druggable proteins within the least influential components.
We found that under both types of perturbations and across all
environmental conditions more druggable proteins were found
among the most influential than the least influential components
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Figure 4 | Enriched biological processes in the most influential components under environmental conditions, and activating perturbations.
(A) Death (B) growth (C) motility and (D) quiescence.

(Figure 6). Druggable proteins are experimentally characterized
or predicted to bind to antagonist or agonist drugs with high
affinity. Therefore, enrichment of druggable proteins within the
most influential components has the potential to suggest important candidates for therapeutic target discovery.

downstream components also affects their upstream component.
In the case of PI3K-out of 42 downstream components, two
(PIP3_345 and RGS) are part of a feedback system. Other feedback
components in downstream targets include alpha_iR for GRK in
inactivating perturbations, Gab1 for SHP2, and Palpha_iR for RKIP
under activating perturbations. We observed that EGFR, a validated
cancer drug target (Mendelsohn, 2001), affects the largest number
of components under activating and inactivating perturbations.

The Most Influential Components as Drug
Targets
Ranked Most Influential Components Based on
Downstream Components

The Most Influential Components Mainly Affect Other
Most Influential Components

We identified the most affected components of the most influential components under both types of perturbations. We combined
all environmental conditions to construct networks of the most
influential components with their downstream targets. We subsequently mapped druggable proteins and cancer-associated genes
on these networks. Under inactivating perturbations, we obtained
a network consisting of the most influential components: PI3K,
EGFR, PP2A, GRK, and CaM (Figure 7A). Under activating
perturbations, we obtained a network composed of influential
components: EGFR, IL1_TNFR, ERK, SHP2, RKIP, Ras, Gbg_i,
Fak, Integrins, and PP2A (Figure 7B).
The total number of downstream targets for each of the most
influential druggable component under both inactivating and
activating perturbations is listed in Table 4. We analyzed if these
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org

Here, we identified all components that directly affect the activity
of each most influential component (KS = 1). Interestingly, most
of these direct upstream components were also ranked as the most
influential in at least one environmental condition (Figure 8).
Under inactivating perturbations, 22 components were directly
upstream of the most influential components. Of these, 19 were
the most influential under at least one environmental condition.
On the other hand, under activating perturbations, out of 45
upstream components, 19 were also ranked as most influential.
Additionally, under inactivating perturbations, 9 (CaM, EGFR,
Gbg_i, GRK, IP3R1, PP2A, PI3K, Ras, and Src) out of total 22
upstream components are druggable. Out of these 22 components, 6 components (CaM, EGFR, Gbg_i, GRK, IP3R1, and
8
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Figure 5 | Distribution of essential genes in the most influential components. X-axis = environmental conditions, Y-axis = ratio of essential genes in total
selected most or least influential components in (A) most influential vs. least influential components under activating perturbations, (B) most influential vs. least
influential components under inactivating perturbations, (C) essential genes in most influential under inactivating vs. activating perturbations, (D) essential genes in
least influential components under inactivating vs. activating perturbations.

PP2A) were upstream to the most influential druggable components. Under activating perturbations, 21 (CaM, Cdc42, EGFR,
Erk, Fak, Gbg_i, Grb2, GRK, IL1_TNFR, Integrins, IP3R1, PDK1,
PI3K, PKA, PP2A, Rac, Raf, Ras, RKIP, SHP2, and Src) out of
45 upstream to the most influential components are associated
with druggable proteins. Out of these 21, 10 components were
also the most influential. Under both types of perturbations, a
total of 18 (alpha_iR, ARF, B_Arrestin, Ca, CaM, EGFR, Gbg_i,
GRK, IP3R1, Palpha_iR, PI5K, PIP2_45, PIP3_345, PP2A, RGS,
PI3K, Ras, and Src) upstream components were common. Nine
of these components (CaM, EGFR, Gbg_i, GRK, IP3R1, PP2A,
PI3K, Ras, and Src) were druggable or these were used as the drug
targets. The important drug targets, such as EGFR, PI3K, Ras,
and Raf, are also appeared as influential upstream components.
Together, these results suggest that under inactivating perturbations the activity of the most influential components are likely to
be modulated by the other most influential components.

in multiple cancer types. However, it is also evident from
literature that several most influential components have been
associated with drug resistance. For example, in non-small
cell lung cancer, mutation within the kinase domain of EGFR
and epithelial–mesenchymal transition are responsible for the
development of resistance to gefitinib (Holohan et al., 2013). In
colorectal, and head and neck cancers, KRAS mutation, EGFRS492R mutation, and increased ErBb signaling are responsible
for resistance against Cetuximab (Dienstmann et al., 2012;
Holohan et al., 2013). Furthermore, PI3K showed drug resistance in breast cancer against rapamycin through the expression
of RSK3 and RSK4 (Rodon et al., 2013). Mutations in ERK1 or
ERK2 have shown resistance against ERK inhibitors or RAF/
MEK inhibitors (Wagle et al., 2014). Tumors with mutation in
BRAF V600E can adapt to the RAF inhibitors (Lito et al., 2013;
Perna et al., 2015). As such, the identification and prediction
of drug targets alone are not sufficient to identify completely
useful drug targets. Investigation of the interactions and feedback of these most influential components could be useful to
modulate the activity of the most influential component. Thus,
we explored the regulatory interactions to investigate the effect
of combinatorial perturbations on cell’s behavior.

The Most Influential Components as Drug Targets
and Drug Resistance

The top most influential components, such as EGFR, PI3K,
ERK, and Ras, have been previously explored as drug targets

Frontiers in Bioengineering and Biotechnology | www.frontiersin.org
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Figure 6 | Distribution of druggable proteins within the most influential vs. least influential components. (A) Inactivating perturbations, (B) activating
perturbations. X-axis = environmental conditions, Y-axis = ratio of druggable proteins in total most or least influential components.

Regulatory Interactions between the Most
Influential Components and Their
Upstream Components

and quiescence. These finding also correlate with published studies
that found that RGS positively regulates apoptosis (Fisher, 2009).
Other examples of consistently occurred interactions include: the
activation of Grb2 leads to increased AL of Ras under all four
environmental conditions, and increased Sos activity under two
environmental conditions stimulating death and quiescence. The
activation of Rac increases the activation of PAK under environmental conditions stimulating cell death and growth. Overall, we
found three types of interactions: inactivation of one component
leads to the increase of activity of another component (PI3K–IP3R1,
IP3R1–PI3K, and RGS–IP3R1), inactivation of a component leads
to decreased activity of another component (IP3R1–RGS), and
activation of a component leads to increased activity of another
component (Grb2–Ras, Grb2–Sos, and Rac–PAK).

To develop a better strategy that can account for drug resistance
of the most important drug targets, we sought to investigate novel
regulatory interactions. We analyzed the previously described
interactions between the most influential components and their
direct upstream components. We found that some interactions
consistently occur in more than one environmental condition. For
example, the inactivation of IP3R1 increases the activity of PI3K
under all four environmental conditions. However, the maximal
effect was observed under the death environmental condition.
Additionally, the inactivation of IP3R1 leads to inactive RGS under
three environmental conditions stimulating cell growth, motility,
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Figure 7 | Visualization of the most affected components (KST value = 1) as a result of perturbing the most influential druggable components. (A)
Inactivating perturbations, (B) activating perturbations. Orange colored eclipeses = most influential druggable components; squares = affected components; orange
colored squares = affected druggable components; components with blue borders = experimentally found to be associated with cancer.
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Table 4 | Number of downstream targets of the most influential druggable components.

EGFR
EGFR
IL1_TNFR
Erk
SHP2
RKIP
PI3K
PP2A
PP2A
Ras
GRK
Gbg_i
Fak
Integrins
CaM

Number of affected
components

Number of affected
druggable components

Number of cancer-associated
components

70
24
54
54
53
43
42
36
5
30
22
15
14
11
8

25
13
14
21
17
12
17
14
3
13
5
5
6
3
5

8
3
5
8
4
7
6
2
5
2
1
4
3
2

Feedback components

1 (Gab1)
1 (Palpha_iR)
2 (PIP3_345, RGS)

1 (alpha_iR)

Perturbation

Inactivating
Activating
Activating
Activating
Activating
Activating
Inactivating
Inactivating
Activating
Activating
Inactivating
Activating
Activating
Activating
Inactivating

Figure 8 | Visualization of the upstream components affecting the most influential components. (A) Inactivating perturbations, (B) activating
perturbations. Gray colored nodes = the most influential components, and white colored nodes = not most influential components. The directions of arrows are
from the source (upstream component) to the target (most influential components).

The fold differences of all these interactions are displayed in
the Table 5. Under the cell death condition, the inactivation of
IP3R1 results in PI3K activity increase by 2.38-fold. Similarly,
PI3K inactivation leads to a 5.42-fold increase in IP3R1 activity.
In the case of other interactions, the inactivation of IP3R1 leads
to inactive RGS under the cell growth, motility, and quiescence
stimulating conditions. Under the motility and quiescence stimulating conditions, the inactivation of Gbg_i leads to inactive CaM.
The activation of Grb2 increases the activity of Ras 7.40-fold

Frontiers in Bioengineering and Biotechnology | www.frontiersin.org

under the cell death stimulating conditions, and 2.13-fold under
the quiescence stimulating conditions. Grb2 activation also
affects Sos 7.8-fold under the cell death stimulating conditions
and 2.18-fold under the quiescence stimulating conditions. An
activating perturbation of Rac increases the activity of PAK more
than 18-fold under the cell death stimulating conditions, and
5.59-fold under the growth stimulating conditions.
To investigate if these interactions are part of any network
motifs in the signal transduction network, we performed a
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Table 5 | Fold differences of the affected most influential component when the upstream component was perturbed.
Perturbed component

Affected component

Fold differences (perturbed/WT)
Death

IP3R1 (inactivation)
PI3K (inactivation)
IP3R1 (inactivation)
RGS (inactivation)
Gbg_i (inactivation)
CaM (inactivation)
Grb2 (activation)
Ras (activation)
Grb2 (activation)
Sos (activation)
Rac (activation)
PAK (activation)

PI3K
IP3R1
RGS
IP3R1
CaM
Gbg_i
Ras
Grb2
Sos
Grb2
PAK
Rac

2.38-Fold
5.42-Folda
NSA
NSA
NSA
NSA
7.40-Folda
0.99-Fold
7.87-Folda
1-Fold
18.41-Folda
1.18-Fold
a

Growth

Motility

Quiescence

1.03-Fold
1.18-Fold
Complete inactivation
1.21-Fold
NSA
NSA
1.32-Fold
0.97-Fold
1.39-Fold
0.97-Fold
5.69-Fold
1.24-Fold

1.04-Fold
1.15-Fold
Complete inactivation
1.18-Fold
Complete inactivation
1.30-Fold
1.39-Fold
0.99-Fold
1.53-Fold
0.99-Fold
NSA
NSA

1.14-Fold
1.24-Fold
Complete inactivation
1.24-Fold
Complete inactivation
1.43-Fold
2.13-Fold
1.01-Fold
2.18-Fold
1.01-Fold
NSA
NSA

NSA, not significantly affected (KST value <1).
a
Twofold or above change.

network motif analysis. We found that all interactions discussed above were part of network motifs (p-value <0.05).
IP3R1–PI3K is found in 3 significantly occurred 4-node
network motifs and in 15 significantly occurred 5-node
network motifs. The other interactions are also found in
significantly occurred 4 and 5-node network motifs (Table S3
in Supplementary Material).
These results suggest different types of regulatory effects of
activating and inactivating perturbations of direct upstream
components of the most influential components.

in the model, the activity level of a total of 15 components (20
genes) increased more than twofold. Nine (60%) of these components were also significantly upregulated in the gene expression
dataset (Table S4 in Supplementary Material). Out of these 20
genes, 9 genes (45%) were upregulated in biological replicate 1,
whereas 12 (60%) genes were upregulated in biological replicate
2. Cumulatively, 18 genes (90%) were upregulated in both biological replicates. Two of these signal transduction components,
Rap1 and PTPPEST, showed significant upregulation in both the
biological replicates in gene expression data. Furthermore, the
activity of a total of 26 components (41 genes) decreased more
than twofold in our model. Genes of eight components (30%)
were significantly downregulated in the obtained gene expression data (Table S4 in Supplementary Material). Out of these
41 genes, three genes (7%) were significantly downregulated
in biological replicate 1, whereas eight genes (19.5%) were significantly downregulated in biological replicate 2. Cumulatively,
12 genes (29%) were upregulated in both biological replicates.
Furthermore, we compared enriched biological processes within
the components affected in the model with enriched biological
processes in differentially expressed genes. We found that the
“regulation of phosphorylation” biological process was enriched
for the upregulated genes in both the model and the gene expression data. For downregulated components, “positive regulation
of programed cell death” was consistent for both the model
and the gene expression data (biological replicate 1). Together,
these results suggest that our simulation results are moderately
correlated with the results of available gene expression data. In
previous integrative studies of gene expression and biochemical
models, at best moderate correlations were observed between
gene expression and metabolic fluxes (Blazier and Papin, 2012).
Post-transcriptional modifications and enzyme kinetics are possible reasons behind poor correlation between gene expression
and protein abundance (Washburn et al., 2003; Blazier and Papin,
2012). As such, more laboratory experiments will be needed to
further validate our results.
Under PI3K inactivation, the average activity of IP3R1
increased from 71.9% in WT to 85.18%. This perturbation also

Cotargeting IP3R1 with PI3K

As discussed earlier, although PI3K was identified as one of
the most influential components, it has been also associated
with drug resistance. Based on the interactions of upstream
regulators of the most influential components discussed above,
we further investigated the interactions involving PI3K and
IP3R1 with the objective of identifying a secondary drug target
that could be potentially used to address the issue of PI3Kassociated drug resistance. In contrast to PI3K/Akt signaling,
IP3R1 positively regulates apoptosis. We hypothesized that
the rate of apoptosis will increase when IP3R1 is overactivated
(activating perturbation) and PI3K is inactivated (inactivation perturbation). Despite the strong dynamical relationship
between IP3R1 and PI3K, these two components are only connected indirectly through a sub-network. In this sub-network,
Gbg_i is upstream of and directly activates both components.
IP3R1 regulates PI3K through a Ca → EGFR route, whereas
PI3K regulates IP3R1 via a PTEN → PIP2_45 → IP3 route
(Figure 9).
The inactivating perturbation of PI3K resulted in the inactivation of 29 components across all four environmental conditions.
To correlate PI3K inhibition results with laboratory experiments,
we analyzed a gene expression dataset obtained from cells treated
with PI3K inhibitors (Rosich et al., 2014). In two biological
replicates, we found that the genes of components with affected
AL had shown differential gene expression (at least in one experiment). As a result of the simulated constitutive inhibition of PI3K
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Figure 9 | The regulatory circuit connecting IP3R1 and PI3K and downstream components. Edges with arrow = activation. Edges with oval
end = inhibition.

Table 6 | Activity of affected components under single (PI3K or IP3R1) and double perturbations (PI3K and IP3R1) under the cell growth environmental
condition.
Affected
components

PI3K inactivation (single
perturbation)a (fold)

IP3R1 activation (single
perturbation)a (fold)

Double perturbationa
(fold)

Rap1
Ca
CaM
CaMKK
Myosin
CaMK

3.25
1.17
1.17
1.17
0.30
1.33

1.07
1.41
1.41
1.41
1.004
2.09

3.90
1.43
1.43
1.43
0.36
2.19

PLA2
AA

0.32
0.32

1.24
1.24

0.63
0.63

a

Functional annotationb

Tumor-suppressor gene
Calcium ion, apoptosis
Cell death
Calcium ion binding, apoptosis
Regulatory light chain of myosin
May function in dendritic spine and synapse
formation and neuronal plasticity
Tumor-suppressor gene, apoptosis
Apoptosis

Compared to the activity of components in wild type.
Functional annotations for proteins were obtained from UniProt database and literature.

b

components: Ca, CaM, CaMK, CaMKK, and RGS in the range of
+1.41- to +2.09-fold when compared to WT.
To simulate the cell death effect under the growth stimulating
condition, we carried out a double perturbation of IP3R1 and
PI3K, whereby IP3R1 was constitutively activated and PI3K was
completely inactivated. Under this combinatorial perturbation,
we found 27 proteins including proto-oncogenes such as Akt
(which suppresses apoptosis) and Raf to be downregulated.
Here, we found eight proteins with more than 19% increased
activity than in the case of a single inactivating perturbation of
PI3K. These proteins include Rap1 (+1.19-fold), Ca (+1.21-fold),
CaM (+1.21-fold), CaMKK (+1.21-fold), Myosin (+1.22-fold),
CaMK (+1.65-fold), PLA2 (+1.98-fold), and AA (+1.98-fold)

led to downregulation of positive regulators of apoptosis phospholipase A2 (PLA2) and arachidonic acid (AA). AA released by
PLA2 triggers Ca2+-dependent apoptosis through mitochondrial
pathways (Penzo et al., 2004). The elevation in Ca2+ is thought
to be involved in apoptosis (Pinton et al., 2008). It was shown
that blocking calcium channels can directly lead to tumor promotion (Mason, 1999). Thus, inactivation of PI3K can block cell
proliferation; simultaneously, it can lower the rate of apoptosis.
Interestingly, the positive regulation of the programed cell death
biological process was enriched in downregulated genes within
the analyzed gene expression data.
Under the cell growth stimulating condition, the activating perturbation of IP3R1 increased the activity of apoptosis-associated
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(Table 6; full list of all affected components is given in Table
S5 in Supplementary Material). These components were downregulated when only PI3K was inactivated. Under the combinatorial perturbation (PI3K inactivated and IP3R1 activated),
the increased activity of these components was achieved by
constitutive expression of IP3R1 via the following routes:
IP3R1 → Ca → CaM → CaMK → Rap1 and IP3R1 → Ca → Ca
M → CaMK → PLA2 → AA (Figure 9). It is noteworthy that these
components have been found to positively regulate apoptosis or
cell death. Therefore, under the aforementioned combinatorial
perturbation, components involved in cell proliferation were
downregulated through the inactivation of PI3K, and the activity
of tumor-suppressor genes (PLA2) with arachidonic acid (AA)
and other components, including Ca, CaM, and CaMK, was
increased as a result of the IP3R1 overactivation.
Together, these results suggest a regulatory interaction
between PI3K and IP3R1, and that cotargeting both of these
components may serve as therapeutic strategy rather than targeting PI3K alone. Using this combination of targets, we simulated
cell death behavior in cell proliferation inducing environmental
condition. Thus, we predict that this novel target combination
might increase the rate of apoptosis while blocking cell proliferation in tumor cells. However, additional experimental validation
is needed to validate this computational result.

environmental conditions. Because essential components are
important from a disease perspective, the identified most influential components may serve as potential candidates and essential
proteins under specific conditions. Under activating perturbations, we found that essential genes were enriched more within
the most influential components than within the least influential
components. The high association of dysregulated signal transduction proteins with different subtypes of cancers suggests
that these components may be important candidates for drug
targets. Notably, the most influential components are enriched
with several already known drug targets. However, many of these
drug targets (EGFR, ERK, Ras, PI3K, etc.) have been associated
with drug resistance (West et al., 2002; Kobayashi et al., 2005;
Linardou et al., 2008; Wheeler et al., 2010; Dienstmann et al.,
2012). The mechanism of drug resistance includes mutation in
the targeted protein or expression of other genes (altered expression) to bypass the effect caused by perturbation, deregulation in
apoptosis, etc. (Gottesman, 2002; Holohan et al., 2013). Thus, to
identify novel regulatory interactions, we explored components
that are upstream to the most influential components associated
with drug resistance. Interestingly, several upstream components (more than 90% in the case of inactivating perturbations)
to the most influential components were also identified as most
influential. Thus, the most influential components form a tightly
connected sub-network of proteins interacting with each other.
In yeast, it has previously shown that the essential proteins are
hubs in the network and have more interconnections than nonessential proteins, and form a module or sub-network (Song and
Singh, 2013).
The interaction between IP3R1 and PI3K was observed under
all environmental conditions. This interaction was also observed
as part of network motifs in the modeled signal transduction
network. IP3R1 activation, when combined with PI3K inactivation, increases the activities of PLA2 and AA, which are decreased
with a single PI3K knockdown. It was already shown that AA
released by PLA2 helps to initiate apoptosis (Penzo et al., 2004).
In a Dictyostelium discoideum chemotaxis experiment, it was also
shown that cells with PI3K deficiency were more sensitive to PLA2
inhibition (Chen et al., 2007), which supports our predicted interaction between PI3K and PLA2. To this end, we hypothesized that
the PI3K inactivation could be combined with the overactivation
of IP3R1 to increase the activity of proteins involved in apoptosis.
IP3R1 inactivation can lead to the downregulation of RGS, and
reversibly, the overexpression of IP3R1 can lead to increased
activity of RGS. Similar to IP3R1, RGS subtype RGS3T has been
found to be involved in inducing cell death (Fisher, 2009), and
it has also been found that RGS can suppress the PI3K activity
downstream of the receptor (Liang et al., 2009). Therefore, the
constitutive activation of IP3R1 might also negatively regulate the
activity of PI3K. Systemic analysis of the most influential components and their upstream components has led us to identify novel
combinations of drug targets. In various studies, combinatorial
therapies have shown a decrease in drug resistance in pathogens.
In combinatorial therapy, a protein associated with drug resistance can be targeted in combination with different protein of
either the same or different pathway (Fischbach, 2011). Clinical
trials have also suggested that the efficiency of cytotoxic drugs

DISCUSSION
We have presented a systemic perturbation analysis of a signal
transduction network model to identify and characterize functionally important components. We used these components to
explore novel therapeutic strategies against cancer. Specifically,
we used a logical modeling approach to analyze the dynamics
of a large-scale signal transduction model. Logical modeling
approaches have been used, for example, to understand the
dynamics of signal transduction and gene regulation networks
to identify drug synergies in gastric cancers, and to identify
potential drug combinations (Flobak et al., 2015). In biochemical
networks, combined effect of topology and dynamical features
has been shown to have the most significant impact on the
dynamics of the network (Kochi et al., 2014). Computational
approaches have become indispensable tools to understand
biological pathways and disease phenotypes. Examples include
computational methods such as molecular modeling, text mining, and network modeling to identify drug targets in a vast array
of diseases from pathogens to complex disorders (Flórez et al.,
2010; Yao et al., 2010; Folger et al., 2011; Madrahimov et al., 2013;
Puniya et al., 2013).
In the present work, the identified most influential components were characterized for biological functions. The relevance
of identified influential components was established with pathway analysis, mapping of housekeeping genes, essential proteins,
and association with druggable proteins. Interestingly, we found
enrichment of housekeeping genes in the most influential components that were independent of the extracellular environments.
A notable agreement is obtained from literature surveys for the
most influential components, which were unique to specific
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